Marksans Pharma Share Price
324.55-7.65 (-2.30%)
+87.58% past 1 Year
News
Marksans Pharma to host analyst and investor meeting on September 2nd
Equity
MARKSANS
Marksans Pharma reports strong quarterly EBITDA growth and margin expansion
Equity
MARKSANS
Marksans Pharma posts strong Q1 revenue growth to Rs 841 crores
Equity
MARKSANS
Marksans Pharma posts sharp rise in quarterly net profit
Equity
MARKSANS
Marksans Pharma to host Q1 FY27 earnings conference call on August 13
Equity
MARKSANS
Marksans Pharma fully acquires Germany-based pharma distributor ABCnow GmbH
Equity
MARKSANS
Marksans Pharma informs about press release
Equity
MARKSANS
Marksans Pharma inks definitive pact to acquire 100% stake in QliniQ B.V.
Equity
MARKSANS
Marksans Pharma to acquire Qliniq B.V. to expand European market presence
Equity
MARKSANS
Marksans Pharma targets Rs 4,000 crores revenue by FY28 with margin guidance
Equity
MARKSANS
Marksans Pharma outlines US launches and new geography revenue timelines
Equity
MARKSANS
Marksans Pharma outlines Australia growth and M&A timeline towards FY27-28
Equity
MARKSANS
Marksans Pharma - Quaterly Results
Equity
MARKSANS
Marksans Pharma posts record revenue and EBITDA, beats margin guidance
Equity
MARKSANS
Marksans Pharma plans to expand North America presence through US store brands
Equity
MARKSANS
Marksans Pharma reports Profit after tax of 91.92 Crores, in the March 2026 quarter
Equity
MARKSANS
Marksans Pharma Q4 EBITDA surges with strong margin expansion year-on-year
Equity
MARKSANS
Marksans Pharma reports strong year-on-year Q4 revenue growth on higher sales base
Equity
MARKSANS
Marksans Pharma Q4 consolidated net profit surges sharply year-on-year
Equity
MARKSANS
Marksans Pharma informs about press release
Equity
MARKSANS